It is well documented that inhalation anaesthetics can increase intracranial pressure (i.c.p.), presumably as a result of cerebral vasodilatation (McDowall, Barker and Jennett, 1966; Jennett et al., 1969; Fitch et al., 1969a; Henriksen and Jorgensen, 1973; . Such increases in i.c.p. are most pronounced in patients with increased i.c.p. or space-occupying lesions, or both, before operation. Although, in most instances, the increases in i.c.p. can be counteracted effectively by the establishment of hypocapnia, the search has continued for anaesthetic techniques which are not associated with such changes. Fitch and others (1969b) observed that the administration of neuroleptanalgesic agents to normocapnic patients anaesthetized with nitrous oxide and following a barbiturate induction decreased existing intracranial hypertension. As a result, we felt it was justified to use these drugs for the induction of general anaesthesia. It was disappointing, therefore, to find that the administration of droperidol 9 mg to an awake patient with an intracranial mass, and marked intracranial hypertension with plateau waves, resulted in a further increase in i.c.p. Similar changes were noted following the addition of fentanyl 0.05 mg. These changes were not related to variations in systemic arterial pressure, central venous pressure or arterial carbon dioxide tension. Because of the results of this pilot study, and also because Fitch and others (1969b) observed, in one patient, an increase of i.c.p. after the administration of neuroleptanalgesic drugs, we felt that it was necessary to study once more the effects of these drugs during controlled conditions, including stable arterial pressure and controlled ventilation, before definite conclusions could be drawn regarding the value of these agents in neuroanaesthesia.
MATERIAL AND METHODS
Eight patients with verified or suspected intracranial space-occupying lesions were studied. Intracranial pressure was recorded for 24-AS h before operation via a catheter in the lateral ventricle opposite to the lesion. Premedication with atropine 0.5 mg and diazepam 5-10 mg was given i.m. 1 h before induction of anaesthesia.
After additional atropine 0.5 mg i.v., anaesthesia was induced using a short-acting barbiturate, enibomal sodium (Narcodorm), 200-350 mg. Suxamethonium 75-100 mg was given to facilitate endotracheal intubation. Respiration was controlled by an Engstrom ventilator with 66% nitrous oxide in oxygen and normocapnia was established. Myoneural block was produced by the repeated administration of gallamine (total: 180-300 mg).
Following the induction of anaesthesia an arterial cannula was placed in the radial artery of the nondominant hand for the continuous monitoring of systemic arterial pressure and for the sampling of blood for the analysis of arterial Po^, Poo i and pH.
Measurement of central venous pressure (c.v.p.) was possible in seven patients via a cubital vein.
Arterial and intracranial pressures were measured using Statham P 23 Db transducers and recorded on a two-channel Servogor potentiometric recorder. C.v.p. was measured using a water column.
The patients were studied in the supine position, all pressures being referred to the forehead level and expressed in mm Hg. The mean pressures (m.a.p., i.c.p.) were calculated by adding one-third of the pulse pressure to the diastolic pressure value, and the cerebral perfusion pressure (c.p.p.) was determined as the difference between mean arterial and mean intracranial pressures.
Blood-gas analyses were performed using standard Radiometer equipment.
Control values {first measurement) were noted, at least 10 min after endotracheal intubation, when a plateau was observed on the pressure tracings. Droperidol 7.5-12.5 mg (mean: 8.75 mg) was now given over a period of 1 min. The second measurement was taken at the point of maximum change in i.c.p. At least 10 min after the injection of droperidol, when a plateau was present again on the pressure curves, third measurement values were obtained. Fentanyl 0.2-0.3 mg (mean: 0.27 mg) was then administered i.v. and the pressure curves were followed until a steady state was achieved when, after at least 10 min, the fourth measurement was read. We attempted to maintain normocapnia up to this point, after which the patients were hyperventilated. The effect of this was studied (fifth measurement) in four patients.
RESULTS
The relevant clinical information is shown in table I. Six patients had moderate to marked intracranial hypertension, and five had plateau waves indicating threatening decompensation of the intracranial pressure regulation.
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